If I’d had a boob job, I wouldn’t be feeling real safe in light of this information:
Aug. 30, 2011 — A panel of expert advisors to the FDA has been asked to solve a mystery: What happened to thousands of women who enrolled in studies designed to evaluate rare complications that might arise years after they received silicone gel breast implants?
In June, after a preliminary review of study data, the FDA concluded that breast implants were largely safe and effective but were not “lifetime devices,” citing high reoperation rates for complications like hardening of the breast and rupture of the implant.
That review also found no evidence that silicone implants were linked to rare problems like breast cancer or connective tissue diseases that have plagued the devices for decades. But the agency also noted that studies were still in progress to better answer some of those questions about rare events.
Now, however, it seems those studies have lost so many of the women they were supposed to follow that they are unlikely to offer any insight into the long-term safety of the devices.